Look for:

NOVARTIS AG


ISIN:
CH0012005267
WKN:
1200526

2020/09/24 10:05:27
Price
80.74 CHF
Difference -0.70% (-0.57)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)170,908 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)80.73 CHF (845)
Ask (Ask size)80.75 CHF (1,478)
Open80.61 CHF
High80.99 CHF
Low80.46 CHF
Close (prev. day)81.31 CHF
VWAP80.67823 CHF
Volume (pcs)670,055
Trading volume54,058,851.54
Number of trades2,988
Last size26

Futures and Options

Related Futures31
Related Options-

PDF Downloads

Annual report: NOVARTIS AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2020/09/24 10:05:31
Price
80.74 CHF
Difference -0.70% (-0.57)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)170,908 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)80.73 CHF (845)
Ask (Ask size)80.75 CHF (1,478)
Open80.61 CHF
High80.99 CHF
Low80.46 CHF
Close (prev. day)81.31 CHF
VWAP80.67823 CHF
Volume (pcs)670,055
Trading volume54,058,851.54
Number of trades2,988
Last size26

Performance and Risk

6M1Y3Y
Perf (%)+16.12%-5.07%+10.22%
Perf (abs.)+11.29-4.34+7.54
Beta0.870.941.00
Volatility22.2925.0020.48
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)81.96 CHF (6,673,464)
Ø price 30 days | Ø volume 30 days (pcs.)79.83 CHF (5,702,133)
Ø price 100 days | Ø volume 100 days (pcs.)81.06 CHF (5,852,500)
Ø price 250 days | Ø volume 250 days (pcs.)84.63 CHF (6,666,685)
YTD High | date96.38 CHF (2020/02/13)
YTD Low | date65.09 CHF (2020/03/16)
52 Weeks High | date96.38 CHF (2020/02/13)
52 Weeks Low | date65.09 CHF (2020/03/16)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2019/06/2822:2580.05 EUR1.31125
SIX Swiss Exchange2020/09/2410:0580.74 CHF54.062,988
Munich2019/06/2813:4780.10 EUR0.002
London Stock Exchange European Trade Reporting2019/06/2813:2688.9205 CHF0.3417
Hanover2019/06/2808:0180.10 EUR0.002
Hamburg2019/06/2814:0580.19 EUR0.084
Frankfurt2019/06/2819:5780.16 EUR0.1313
FINRA other OTC Issues2020/09/2321:3188.2875 USD1.9415
Duesseldorf2019/06/2814:0880.18 EUR0.002
Berlin2019/06/2818:4580.40 EUR0.0016

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2284&ID_TYPE_IMAGE_LOGO=2

Contact Details

NOVARTIS AG
Samir Shah
Lichtstrasse 35 CH-4002 Basel
Telefon: +41-61-324-1111
Fax: +41-61-324-8001
E-mail: investor.relations@novartis.com

PDF Downloads

Annual report: NOVARTIS AGPDF Download

Company Profile

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. Novartis products are sold in approximately 155 countries around the world.

Members of Management Board

Vasant Narasimhan, M.D.Chairman of Managing Board
Steven BaertMember of Executive Committee
Shannon Thyme KlingerMember of Executive Committee
Robert WeltevredenMember of Executive Committee
Richard SaynorMember of Executive Committee
Marie-France TschudinMember of Executive Committee
John TsaiMember of Executive Committee
Harry KirschMember of Executive Committee
Bertrand BodsonMember of Executive Committee
Susanne SchaffertMember of Executive Committee
Steffen LangMember of Executive Committee
Klaus MoosmayerMember of Executive Committee
James E. BradnerMember of Executive Committee

Board of directors

William T. WintersMember of the administrative board
Ton BuechnerMember of the administrative board
Simon MoroneyMember of the administrative board
Patrice BulaMember of the administrative board
Frans van HoutenMember of the administrative board
Elizabeth DohertyMember of the administrative board
Charles L. SawyersMember of the administrative board
Bridgette HellerMember of the administrative board
Ann FudgeMember of the administrative board
Srikant DatarMember of the administrative board
Nancy C. AndrewsMember of the administrative board
Enrico VanniMember of the administrative board
Charlotte Pamer-WieserMember of the administrative board
Andreas von PlantaMember of the administrative board
Joerg ReinhardtChairman of the administrative boar





Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.